Company intelligence / Profile preview

QSAR Lab

Gdańsk, Pomeranian, Poland
Ownership
Private
Employees
~32
Development stage
Other
01

Overview

QSAR Lab is a private Polish computational chemistry and digital toxicology company that provides in silico R&D and regulatory-support services for chemicals, nanomaterials, peptides, and related life-science applications. The company uses QSAR/QSPR modeling, read-across, machine learning, and AI to design safer chemicals and advanced materials, predict toxicological and physicochemical properties, and support REACH- and OECD-aligned risk assessment workflows. Its offerings span digital design of chemicals and nanomaterials, digital toxicity assessment, AI/ML data analysis, training, and R&D consulting. QSAR Lab also develops software and data platforms including PredMat for nanomaterials, PeptAIm for peptide design, PredSuite for ready-to-use predictive models, and NAMs.network for New Approach Methodologies resources. The company appears to operate primarily as a services and platform business rather than a therapeutic drug developer.

Therapeutic areas
Other
Modalities
Small moleculePeptidesNanoparticle
Industry
Drug Discovery Services
02

Partnerships

Horizon 2020 PATROLS project consortiumHorizon 2020 NanoSolveIT project consortiumHorizon 2020 CompSafeNano project consortiumHorizon 2020 RiskGONE project consortiumNOUVEAU project consortiumNANO-ENGINE project consortium

Beyond the preview

Go deeper on QSAR Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on QSAR Lab.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call